Free EHR, EHR and Healthcare IT Newsletter Want to receive the latest updates on EHR, EMR and Healthcare IT news sent straight to your email? Get all the latest EHR News for FREE!

Kyruus Raises $10 Million to Fuel Continued Growth

Patient Access Leader Investing in Product Innovation & Partnerships to Meet Fast-Growing Demand

Boston, MA – Kyruus, a leader in provider search and scheduling solutions for health systems, today announced that it has raised $10 million in new financing in a strategic round. The new financing comes on the heels of a year of unprecedented growth in which the company doubled its revenue and increased the number of hospitals on its platform by 50%. Kyruus will primarily use the investment to grow its product development and delivery teams to support the expansion of its platform, integrations with additional leading players in the digital health ecosystem, and ongoing customer success.

Health systems across the country are putting a heavy focus on the “front doors” of their organizations – online and offline access points that set the tone for the patient’s entire experience with the health system. Already offering the only enterprise-wide patient access solution on the market, this latest financing round will enable Kyruus to deepen its product capabilities and further support its customers’ patient access strategies beyond the traditional walls of a health system. In addition, it will facilitate Kyruus’ growing partnerships with industry leaders offering complementary solutions to support health systems’ access initiatives. Building on its partnership with Salesforce last year, Kyruus announced a collaboration with IBM Watson last month and its membership in the Epic App Orchard earlier this year.

Kyruus counts many of the leading health systems in the US among its customer base, which now includes more than 400 hospitals. In the past year alone, major new customer announcements included Piedmont HealthcareJefferson Health, and University of Miami Health System. Its customers are increasingly deploying the company’s solutions at multiple access points as well. Last month Kyruus announced a major expansion with Partners HealthCare that involved the health system not only expanding to use both Kyruus’ consumer and access center solutions, but also deploying ProviderMatch across its network.

Providence St. Joseph Health (through its venture capital fund, Providence Ventures) is one of two health systems that have invested in Kyruus.“At a time when there are so many solutions trying to address a piece of the access puzzle, Kyruus offers a truly foundational platform,” said Aaron Martin, EVP & Chief Digital Officer at Providence St. Joseph Health and Managing General Partner, Providence Ventures. “As a customer and investor, it’s been great to be part of Kyruus’ growth and we look forward to partnering with them as they continue to pave the way in helping more people in our communities access our care.”

“We’re excited to cap off a momentous year for the company with new funding to support our next phase of growth,“ said Graham Gardner, CEO of Kyruus. “With patient access a growing strategic priority for health systems nationwide, we are now poised to extend both our platform and partner ecosystem to keep our customers ahead of the curve.”

Kyruus is financed by some of the leading venture capital firms, technology companies, and health systems in the US. This includes Venrock, Highland Capital, New Leaf Venture Partners, Leerink Transformation Partners, F-Prime Capital Partners, Fidelity Biosciences, McKesson Ventures, Lux Capital, and Providence Ventures. The company is currently headquartered in the Back Bay area of Boston, but will be moving to a new office in the Seaport area this summer to accommodate growth in its employee base.

About Kyruus

Kyruus delivers proven provider search and scheduling solutions that help hospitals and health systems match patients with the providers best suited to care for them. The ProviderMatch suite of solutions—for consumers, access centers, and referral networks—enables a consistent patient experience across multiple points of access, while aligning provider supply with patient demand. The company’s proprietary provider data management platform forms the foundation of its solutions, powering them with accurate data by coupling data processing with administrative applications. To find out why a Better Match Means Better Care, please visit www.kyruus.com

April 18, 2018 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

IBM Watson Health Announces New Partnerships, New Cloud Services and Global HQ in Cambridge, MA

Veteran Health/Tech Leader Deborah DiSanzo Joins IBM Watson Health as General Manager

Introduces IBM Watson Health Cloud for Life Sciences Compliance and IBM Watson Care Manager

Boston Childrens Hospital, Columbia University, ICON plc, Sage Bionetworks & Teva Pharmaceuticals Join the Roster of Industry Leaders Leveraging the Power of Watson

IBM Watson Health Global Headquarters Planned for Cambridges Kendall Square

CAMBRIDGE, MA 10 Sept 2015: Opening its new IBM Watson Health global headquarters in Cambridge, Mass., IBM (NYSE: IBM) today announced that Deborah DiSanzo is joining the company as the business unit’s General Manager, introduced a pair of new cloud services, and revealed major new partnerships — all reflecting IBM’s commitment to helping advance the quality of health globally.

DiSanzo brings to IBM, its partners and its clients more than 30 years’ experience working at the intersection of healthcare and technology, most recently as CEO for Philips Healthcare. She will lead more than 2,000 IBMers, with a mandate to scale the business globally, expand the capabilities of the IBM Watson Health Cloud, and broaden a growing ecosystem that is building on IBM’s technology platform. Further, she will oversee a fast growing roster of clients, collaborators and partners that includes marquis relationships with Johnson & Johnson, Apple, Medtronic, Epic, and CVS Health, among others. She will report to IBM Watson Group leader Michael Rhodin.

IBM also expanded its solutions portfolio with the introduction of IBM Watson Health Cloud for Life Sciences Compliance and IBM Watson Care Manager:

  • The IBM Watson Health Cloud for Life Sciences Compliance will help biomedical companies bring medical innovations to market more efficiently. This first-in-class solution will help the companies fast-track the deployment of a GxP compliant infrastructure and applications while adhering to stringent requirements for hosting, accessing and sharing regulated data.
  • IBM Watson Care Manager is a population health solution that uniquely integrates capabilities from Watson Health, Apple’s HealthKit and ResearchKit, a software framework designed by Apple to make it easy for researchers to conduct studies using an iPhone. It allows medical professionals’ to factor a broad range of determinants into a personalized patient engagement program, with the intent to vastly improve individual health outcomes.

In addition, IBM announced that Boston Children’s Hospital, Columbia University, ICON plc, Sage Bionetworks and Teva Pharmaceuticals will join the roster of industry leaders that are leveraging Watson’s capabilities to transform key aspects of the healthcare ecosystem that include drug discovery and development, personalized medicine, chronic disease management, pediatrics, and digital health. They join CVS Health, Medtronic and Yale University, among others. Teva and Sage both announced the Watson Health Cloud is their organizations’ preferred development platform.

“Watson Health is driving a new era of technology-driven health, enabling entrepreneurs and industry leaders to address diverse needs, spanning the earliest stages of research all the way through to clinical care and population health through to consumer wellness,” said Mike Rhodin, Senior Vice President, IBM Watson Group. “The variety of new partners and use cases underscores the flexibility and scalability of the IBM Watson Health Cloud to help leaders rapidly advance the state of the art in health and wellness. Further, IBM Watson Health is building for scale, with partners, offerings and now a worldwide headquarters designed to help global organizations meet the world’s pressing health needs.”

The opening ceremony also featured demonstrations by health ecosystem partners Best Doctors, Modernizing Medicine, Pathway Genomics, Socrates and Welltok, which showed how Watson is being deployed in solutions such as enabling cost-effective second opinion services, helping optimize physician practice patterns, and supporting consumers’ ability to make informed, cost effective medical choices.

IBM Watson Health Attracts Start-Ups and Established Leaders

IBM Watson Health has achieved significant market momentum since it was introduced five months ago. Hundreds of partners, ecosystem members and customers are working with IBM to address unmet needs across the continuum of life sciences and healthcare. New collaborations announced today include:

Boston Childrens Hospital has been named Watson Health’s foundational pediatrics partner, building on an existing relationship between the two entities. IBM will integrate Watson’s deep and iterative question and answer capability to enhance and scale the OPENPediatrics initiative, a ground-breaking BCH initiative which aims to bring life-saving medical knowledge to pediatric caregivers worldwide. Moving forward, BCH and IBM will jointly develop solutions for commercialization, initially pursuing applications in personalized medicine, heart health and critical care with the potential to leverage Watson Genomic Analytics to assist researchers and clinicians in the treatment of rare pediatric disease; apply Watson’s image analytics capabilities with the intent to help clinicians improve diagnoses for children facing heart heath conditions; and apply streaming analytics to data from patients on ventilation systems, with the intent to help to medical professionals predict patient decline before it occurs.

Columbia University Medical Centers departments of Pathology & Cell Biology and Systems Biology will collaborate with IBM to test using IBM Watson to help oncologists in the Columbia Herbert Irving Comprehensive Cancer Center translate DNA insights into personalized treatment options for patients. Columbia is the 16th cancer center to test the use Watson Genomic Analytics to bring precision medicine to patients worldwide. As Columbia and other institutions evaluate Watson’s ability to help clinicians in identifying actionable mutations in cancer, Watson’s rationale and insights will continually improve, providing the latest combined wisdom of the world’s leading cancer institutes in a scalable, cloud-based solution.

ICON plc is the first global clinical research organization (CRO) to apply Watson to clinical trial matching, tapping into data in the IBM Watson Health Cloud to help its biomedical customers accelerate medical research and the development of new treatment options for patients. It is estimated that 80 percent of clinical trials fail or are delayed due to inadequate patient enrollment and only 2 percent of eligible patients become trial subjects. ICON will leverage Watson to automate the cumbersome process of identifying patients who meet the criteria for a clinical trial. Watson will also analyze trial protocols against a massive volume of patient data in the Watson Health Cloud to assess trial feasibility and identify optimal trial sites.

Sage Bionetworks Open Biomedical Research Platform will be powered by the IBM Watson Health Cloud, with the intent to make the IBM Watson Health Cloud the platform of choice for Sage to aggregate, store, curate, and analyze data collected via apps using ResearchKit. Sage currently has active ResearchKit projects in breast cancer and Parkinson’s Disease. Further, Sage and IBM will collaborate to integrate the IBM Watson Health Cloud with Sage’s BRIDGE server and Synapse, an informatics platform dedicated to supporting the large-scale pooling of data, knowledge, and expertise across institutions to solve some of the most challenging problems in biomedical research. Sage endeavors to engage patients in the scientific discovery process and facilitate global collaboration among researchers working toward a shared goal of advancing and accelerating medical research.

“Successful biomedical research requires active participation and data sharing across a wide variety of stakeholders,” said Stephen H. Friend, MD, PhD, president, co-founder and director, Sage Bionetworks. “The IBM Watson Health Cloud can help us break down barriers that hamper progress in research and accelerate discovery through open collaboration by providing broadly accessible storage with large capacity.”

Teva Pharmaceuticals announced that IBM Watson Health Cloud will serve as Teva’s global technology platform of choice to build solutions designed to help millions of individuals worldwide with complex and chronic conditions such as asthma, pain, and neurodegenerative diseases. Teva expects to introduce its first e-health solution in 2016.

IBM Watson Health Global Headquarters Established in Cambridge Life Science Hub

Unveiled today, Watson Health’s global headquarters are located at 75 Binney Street in Cambridge’s Kendall Square and will serve as a home base for more than 700 IBM employees.

For entrepreneurs and start-ups, Watson Health’s Cambridge headquarters will provide technology, tools and talent to create and launch new products and businesses based on Watson’s cloud-delivered cognitive intelligence. IBM intends to open an interactive Watson Health Experience Center in Cambridge, which will serve as a place for IBM clients to undertake immersive leaning about Watson and how it can help transform their businesses. In addition, IBM Research will establish a dedicated Health Research lab at the headquarters, deepening IBMs decades-long commitment to investigation that informs new IBM offerings.

Cambridge is widely considered the epicenter of the Life Sciences industry, and Massachusetts boasts more than 600 life sciences companies and research organizations employing roughly 60,000 people with a combined payroll topping $7 billion annually, according to the Massachusetts Biotechnology Council. In recent years, Massachusetts has drawn more than 20 percent of all venture capital outlays for biotechnology companies nationally and the majority of grants from the National Institutes of Health.

IBM Watson: Pioneering a New Era of Computing

Watson is the first commercially available cognitive computing capability representing a new era in computing. The system, delivered through the cloud, analyzes high volumes of data, understands complex questions posed in natural language, and proposes evidence-based answers. Watson continuously learns, gaining in value and knowledge over time, from previous interactions. In April 2015, the company launched IBM Watson Health and the Watson Health Cloud platform. The new unit will help improve the ability of doctors, researchers and insurers to innovate by surfacing insights from the massive amount of personal health data being created daily. The Watson Health Cloud allows this information to be de-identified, shared and combined with a dynamic and constantly growing aggregated view of clinical, research and social health data.

For more information on IBM Watson, visit: ibm.com/watson. For more information on IBM Watson Health, visit: ibm.com/watsonhealth

Check out the IBM Watson press kit at: http://www-03.ibm.com/press/us/en/presskit/27297.wss

Join the conversation at #ibmwatson and #watsonhealth.   Follow Watson on Facebook and see Watson on YouTube and Flickr.

Learn more about this story at http://asmarterplanet.com/blog/2015/09/taking-new-era-computing-healthcare.html

Learn more about our collaboration with ICON Clinical Research at http://asmarterplanet.com/blog/2015/09/using-data-analytics-speed-clinical-drug-trials.html

September 10, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.

IBM Acquires Explorys to Accelerate Cognitive Insights for Health and Wellness

Armonk, NY and Cleveland – 13 April 2015: IBM (NYSE: IBM) today announced it has acquired Explorys, a healthcare intelligence cloud company that has built one of the largest clinical data sets in the world, representing more than 50 million lives. The acquisition strengthens IBM’s leadership position in healthcare analytics and cloud computing, and will help bolster its ability to extract and share deep insights to improve wellness and benefit patients.

Since its spin-off from the Cleveland Clinic in 2009, Explorys has secured a robust healthcare database derived from numerous and diverse financial, operational and medical record systems comprising 315 billion longitudinal data points across the continuum of care. This powerful body of insight will help fuel IBM Watson Health Cloud, a new open platform that allows information to be securely de-identified, shared and combined with a dynamic and constantly growing aggregated view of clinical, health and social research data.

Explorys provides secure cloud-based solutions for clinical integration, at-risk population management, cost of care measurement, and pay-for-performance. Headquartered in Cleveland, Explorys clients include some of the most prominent healthcare systems in the United States, together accounting for over $69 billion in care, 360 hospitals and more than 317,000 providers. Explorys’ HIPAA-enabled cloud-computing platform is used by 26 healthcare systems and clinically integrated networks to identify patterns in diseases, treatments and outcomes. Its network includes Cleveland Clinic, Trinity Health, St. Joseph Health System, Mercy Health, Adventist Health System and many others with patients across the country. Market intelligence firm IDC just named Explorys global leader in Healthcare Clinical and Financial Analysis.

“As healthcare providers, health plans and life sciences companies face a deluge of data, they need a secure, reliable and dynamic way to share that data for new insight to deliver quality, effective healthcare for the individual,” said Mike Rhodin, senior vice president, IBM Watson. “To address this opportunity, IBM is building a holistic platform to enable the aggregation and discovery of health data to share it with those who can make a difference. With Explorys, IBM will accelerate the delivery of IBM Health Cloud and IBM Watson cognitive solutions to model and apply medical evidence and large scale analytics to data.”

“Every encounter that a patient has across the continuum of care spins off a meaningful piece of data that can help tell the whole story about an individual’s health to improve the quality and effectiveness of their care,” said Stephen McHale, CEO and co-founder, Explorys. “Information is changing the way care is delivered and paid for. The combination of Explorys technology with IBM’s powerful Health Cloud and Watson cognitive capabilities will expand the reach of health insights so that Big Data can finally be used more easily to transform healthcare. This relationship will not only accelerate but enhance many of the projects underway with our provider organizations.”

Explorys is now part of IBM’s new Watson Health unit, launched today. Its offerings complement and strengthen the IBM Watson Health Cloud platform and will empower IBM’s vast ecosystem of clients, partners and medical researchers to surface new connections among diverse and previously siloed healthcare data sets. Access to these insights is expected to spur the creation of a new generation of data-driven applications and solutions designed to advance health and wellness.

Financial terms were not disclosed.

About Explorys

Originally inspired by physicians and informatics leaders, Explorys combines the most powerful healthcare computing platform in the world with turnkey solutions for clinical integration, at-risk population management, cost of care measurement, and pay-for-performance solutions. Explorys addresses the national imperative to leverage Big Data in healthcare for the improvement of medicine and delivery of care. For more information, please visit www.explorys.com.

About IBM Watson Health

IBM and its vast ecosystem of clients, partners and medical researchers are accelerating the development of a new generation of data-driven applications and solutions built on IBM Health Cloud and IBM Watson cognitive solutions to advance health and wellness. For more information, please visit ibm.com/watsonhealth.

April 15, 2015 I Written By

John Lynn is the Founder of the HealthcareScene.com blog network which currently consists of 5 blogs containing over 11,000 articles with John having written over 5500 of the articles himself. These EMR and Healthcare IT related articles have been viewed over 18 million times. John also manages Healthcare IT Central and Healthcare IT Today, the leading career Health IT job board and blog. John is co-founder of InfluentialNetworks.com and Physia.com. John is highly involved in social media, and in addition to his blogs can also be found on Twitter: @techguy and @ehrandhit and LinkedIn.